Posted on October 30th, 2009 by Health News
AcelRx Pharmaceuticals, Inc. today announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company’s proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
Isotechnika Pharma Inc. today announced that it has developed a portfolio of non-immunosuppressive cyclosporine analogue molecules (NICAMs) with potent cyclophilin inhibition. Cyclophilin inhibition has garnered considerable attention as a novel therapy in the treatment of a wide range of diseases including hepatitis C, stroke, and chronic neurological disorders such as Parkinson’s, Lou Gehrig’s, and Alzheimer’s.
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
Dynavax Technologies Corporation today announced the first clinical data for HEPLISAVTM investigational hepatitis B vaccine in chronic kidney disease patients.
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company’s two year-long phase 3 obesity trials [...]
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
Foreign pharmaceutical companies on Wednesday accepted the decision of Ecuador’s President Rafael Correa to enable the country “to bypass patents on 2,000 drugs in order to produce them locally or buy cheaper versions elsewhere,” Agence France-Presse reports. “‘We accept the democratic decision …
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
Transcept Pharmaceuticals (Nasdaq: TSPT) announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). The NDA, submitted by Transcept in September 2008, seeks approval to market Intermezzo® for use as-needed for the treatment of insomnia when a middle of [...]
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
The comparative study of chronic wound treatment at the Hospital Civil of Cd. Victoria, Tamaulipas, Mexico, was concluded successfully. Due to the significantly superior therapeutic success the Ministry of Health ordered the control to be abandoned and moved to Hemospray treatment for ethical reasons. 22 of the 24 patients within the Hemospray group were healed [...]
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
China Medicine Corporation, a developer and leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (”TCM”), nutritional and dietary supplements, and medical devices and medical formulations, today announced that through its wholly-owned subsidiary in China, Konzern Pharmaceuticals, it has signed an equity transfer agreement (the “Transfer Agreement”) to acquire 100% of equity interests in [...]
No Comments »
Filed under: Pharmacy News
Posted on October 30th, 2009 by Health News
Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR® (fenofibrate) tablets, 48 mg and 145 mg.
No Comments »
Filed under: Pharmacy News
